Nottingham Prognostic Index Plus (NPI+): a modern clinical decision making tool in breast cancer.
about
Breast cancer classification and prognostication through diverse systems along with recent emerging findings in this respect; the dawn of new perspectives in the clinical applications.Improving the Prognostic Ability through Better Use of Standard Clinical Data - The Nottingham Prognostic Index as an Example.Classification of patients with breast cancer according to Nottingham prognostic index highlights significant differences in immunohistochemical marker expression.Effect of PREDICT on chemotherapy/trastuzumab recommendations in HER2-positive patients with early-stage breast cancer.Exploring the spatial dimension of estrogen and progesterone signaling: detection of nuclear labeling in lobular epithelial cells in normal mammary glands adjacent to breast cancer.Differential immune cell densities in ductal carcinoma In-Situ and invasive breast cancer: Possible role of leukocytes in early stages of carcinogenesis.Evaluation of Tumor Cell Proliferation by Ki-67 Expression and Mitotic Count in Lymph Node Metastases from Breast Cancer.Prognostic contribution of mammographic breast density and HER2 overexpression to the Nottingham Prognostic Index in patients with invasive breast cancerNottingham Prognostic Index Plus: Validation of a clinical decision making tool in breast cancer in an independent series.Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancer.Maspin Gene Expression in Invasive Ductal Carcinoma of Breast.A Prognostic Model for Patients with Triple-Negative Breast Cancer: Importance of the Modified Nottingham Prognostic Index and Age.Clinical utility of reverse phase protein array for molecular classification of breast cancer.More than meets the eye: the changing face of histopathology.S100A14 is a novel independent prognostic biomarker in the triple-negative breast cancer subtype.Risk of recurrence estimates with IHC4+C are tolerant of variations in staining and scoring: an analytical validity study.Intelligent Techniques Using Molecular Data Analysis in Leukaemia: An Opportunity for Personalized Medicine Support System.Correlation analysis between molecular subtypes and Nottingham Prognostic Index in breast cancer.Molecular Genomic Testing for Breast Cancer: Utility for Surgeons.Expression of Fibroblast Growth Factor 5 (FGF5) and Its Influence on Survival of Breast Cancer Patients.Survival estimates stratified by the Nottingham Prognostic Index for early breast cancer: a systematic review and meta-analysis of observational studies
P2860
Q30245184-C0FE1E92-ABA6-49DC-902F-44DED77D9CA3Q31052319-5ABA3FE8-5B29-4C43-A632-E9E22C164723Q34042565-C928F3C2-E5AA-44D2-8433-AB9F78270373Q34427448-8F06AD5C-C324-4A15-9DDD-AF30A1C5F3ADQ35011470-BEA19153-9710-4C37-8F55-33D16746EBB1Q35765833-C5B7B01D-8D4B-4A8D-A3E5-FA25559895DAQ35949311-78AD11A3-ACE1-44F6-8A37-3C6B909164F3Q36180689-50A5DB8E-291B-4D80-B959-A1076FCA82D4Q36873822-EB31DF2D-67D1-4C56-81B1-9FFAB111D9ECQ36908377-0A36FDFB-339D-4E5D-AA26-D3991AB677F5Q37081835-13C42B56-14EA-4C88-A304-23CD903C1771Q37735965-1AA488B1-43B2-42A7-8E38-6CB3FB86EE55Q38383140-574A39BB-BD8F-4DB0-9990-35FCB15A763CQ38783398-2228B59B-911F-4CD9-90CB-92A4DCC73423Q38882282-DAE57C17-C05F-4197-9190-8DA63AFF3E61Q40634876-332F9820-C522-40EB-8499-928611E43770Q41294047-84823DED-82F1-4AFB-94B8-B4E7FC4E2038Q47131447-5BC7DB2A-5D5D-49B8-88BB-B39EA95C19D9Q49843589-15105AE2-34EC-477F-B33C-9ECE6C95B103Q55365778-9CA0B1DD-DA0B-4A29-88AB-AFAAF6546C8BQ57105929-2D62039C-794C-4285-8AF9-D4B23B765461
P2860
Nottingham Prognostic Index Plus (NPI+): a modern clinical decision making tool in breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nottingham Prognostic Index Pl ...... making tool in breast cancer.
@en
Nottingham Prognostic Index Plus
@nl
type
label
Nottingham Prognostic Index Pl ...... making tool in breast cancer.
@en
Nottingham Prognostic Index Plus
@nl
prefLabel
Nottingham Prognostic Index Pl ...... making tool in breast cancer.
@en
Nottingham Prognostic Index Plus
@nl
P2093
P2860
P50
P356
P1476
Nottingham Prognostic Index Pl ...... n making tool in breast cancer
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.2014.120
P407
P577
2014-03-11T00:00:00Z